TEK and Sepsis: The observation that the Ang/Tie2 pathway contributes to disease pathobiology and that circulating ligands of Tie2, Ang1, and Ang2 can risk-stratify critically ill patients suggests that this pathway is a therapeutic target to prevent microvascular leak associated with sepsis.